JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M413437200 on January 24, 2005

J. Biol. Chem., Vol. 280, Issue 17, 17235-17242, April 29, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/17/17235    most recent
M413437200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chinami, M.
Right arrow Articles by Adra, C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chinami, M.
Right arrow Articles by Adra, C. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Binding of HTm4 to Cyclin-dependent Kinase (Cdk)-associated Phosphatase (KAP)·Cdk2·Cyclin A Complex Enhances the Phosphatase Activity of KAP, Dissociates Cyclin A, and Facilitates KAP Dephosphorylation of Cdk2*

Masanobu Chinami,ab Yoshihiko Yano,bc Xing Yang,bc Saira Salahuddin,c Kosei Moriyama,d Mitsunori Shiroishi,e Helen Turner,f Taro Shirakawa,gh and Chaker N. Adracij

From the aDepartment of Nutrition, Kyushu Women's University, Jiyugaoka 1-1, Kitakyushushi 807-8586, Japan, the cDepartment of Medicine, Beth Israel Deaconess Medical Center, and iDepartment of Medicine, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02215, dDepartment of Internal Medicine, Fukuoka Dental School, Tamura, Sawaraku 2-15-1, 814-0193 Fukuoka, Japan, eMedical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan, fQueen's Center for Biomedical Research, Queen's Medical Center, Honolulu, Hawaii 96813, gDepartment of Health Promotion and Human Behavior, Kyoto University Graduate School of Public Health, Kyoto 606-8501, Japan, and hRIKEN SNP Typing Center, Shirokanedai 4-6-1, Tokyo 108-8639, Japan

Cyclin-dependent kinase 2 (cdk2) activation requires phosphorylation of Thr160 and dissociation from cyclin A. The T-loop of cdk2 contains a regulatory phosphorylation site at Thr160. An interaction between cdc-associated phosphatase (KAP) and cdk2 compromises the interaction between cdk2 and cyclin A, which permits access of KAP, a Thr160-directed phosphatase, to its substrate, cdk2. We have reported that KAP is bound and activated by a nuclear membrane protein, HTm4. Here, we present in vitro data showing the direct interaction between the HTm4 C terminus and KAP Tyr141. We show that this interaction not only facilitates access of KAP to Thr160 and accelerates KAP kinetics, but also forces exclusion of cyclin A from the KAP·cdk2 complex.


Received for publication, November 30, 2004 , and in revised form, January 7, 2005.

* This work was supported by Grant AI 43663 from the NIAID, National Institutes of Health, Grant RSG-01-241-01-LIB from the American Cancer Society (to C. N. A.), by grant-in-aid for Exploratory Research MEXT 15659112 from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by the Adra family. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

b These authors contributed equally to this work.

j To whom correspondence should be addressed: Dept. of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 99 Brookline Ave., Boston, MA 02215. Tel.: 617-667-3766; Fax: 617-975-7905; E-mail: cadra{at}caregroup.harvard.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Yu, X. Jiang, B. S. Schoch, R. S. Carroll, P. M. Black, and M. D. Johnson
Aberrant Splicing of Cyclin-Dependent Kinase-Associated Protein Phosphatase KAP Increases Proliferation and Migration in Glioblastoma
Cancer Res., January 1, 2007; 67(1): 130 - 138.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.